SLS SELLAS LIFE SCIENCES GROUP INC Delisting Actions 8-K Filing 2024 - Delisting SELLAS Life Sciences Group, Inc. received a notice from Nasdaq stating that their common stock did not maintain a minimum closing bid price of $1.00 per share as required by Nasdaq Listing Rule 5550(a)(2). The company has a grace period of 180 days to regain compliance.Get access to all SEC 8-K filings of the SELLAS LIFE SCIENCES GROUP INC